Kimberly Chong

Array ( [id] => 1012548 [patent_doc_number] => 06897019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Methods for treating and preventing insulin resistance and related disorders' [patent_app_type] => utility [patent_app_number] => 09/690647 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 25365 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897019.pdf [firstpage_image] =>[orig_patent_app_number] => 09690647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795732 [patent_doc_number] => 07429648 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-30 [patent_title] => 'IREN protein, its preparation and use' [patent_app_type] => utility [patent_app_number] => 10/070255 [patent_app_country] => US [patent_app_date] => 2000-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 15 [patent_no_of_words] => 24544 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429648.pdf [firstpage_image] =>[orig_patent_app_number] => 10070255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503774 [patent_doc_number] => 08742090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses' [patent_app_type] => utility [patent_app_number] => 08/978632 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 39398 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 08978632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876661 [patent_doc_number] => 20010006814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'NOVEL PROPERTY EFFECTING AND/ OR PROPERTY EXHIBITING COMPOSITIONS FOR THERAPEUTIC AND DIAGNOSTIC USES' [patent_app_type] => new-utility [patent_app_number] => 08/978633 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 39577 [patent_no_of_claims] => 244 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006814.pdf [firstpage_image] =>[orig_patent_app_number] => 08978633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 407971 [patent_doc_number] => 07285288 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-23 [patent_title] => 'Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides' [patent_app_type] => utility [patent_app_number] => 09/381747 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 16387 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285288.pdf [firstpage_image] =>[orig_patent_app_number] => 09381747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 380117 [patent_doc_number] => 07309692 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-18 [patent_title] => 'Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1' [patent_app_type] => utility [patent_app_number] => 08/679437 [patent_app_country] => US [patent_app_date] => 1996-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9782 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309692.pdf [firstpage_image] =>[orig_patent_app_number] => 08679437 [rel_patent_id] =>[rel_patent_doc_number] =>)